Search research articles
Contact Us
Filters
Showing results (61-70 of 118) with videos related to
Page
of 12
Sort By:
Cell Reports
|
May 12, 2021
Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8<sup>+</sup> T cell antiviral responses
Hongbing Yang, Anuska Llano, Samandhy Cedeño, et al.
AIDS (London, England)
|
October 17, 2018
Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
Morgane Gossez, Genevieve Elizabeth Martin, Matthew Pace, et al.
AIDS Research and Human Retroviruses
|
December 6, 2016
Short Communication: Lack of Effect of Maraviroc Intensification on Blood and Gut Reservoir
Juan Tiraboschi, Shuvra Ray, Kemal Patel, et al.
The Journal of Infectious Diseases
|
November 29, 2019
Levels of Human Immunodeficiency Virus DNA Are Determined Before ART Initiation and Linked to CD8 T-Cell Activation and Memory Expansion
Genevieve E Martin, Matthew Pace, Freya M Shearer, et al.
Plos Pathogens
|
July 15, 2016
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection
Matthias Hoffmann, Nikos Pantazis, Genevieve E Martin, et al.
AIDS (London, England)
|
June 15, 2021
Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohort
Luke A Granger, Isabella Huettner, Franka Debeljak, et al.
Mucosal Immunology
|
June 27, 2019
CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype
John P Thornhill, Matthew Pace, Genevieve E Martin, et al.
Frontiers in Immunology
|
May 22, 2018
CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA
Genevieve E Martin, Matthew Pace, John P Thornhill, et al.
Elife
|
September 14, 2014
HIV-1 DNA predicts disease progression and post-treatment virological control
James P Williams, Jacob Hurst, Wolfgang Stöhr, et al.
The New England Journal of Medicine
|
January 18, 2013
Short-course antiretroviral therapy in primary HIV infection
, Sarah Fidler, Kholoud Porter, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 118) with videos related to
Sort By:
Page
of 12
Cell Reports
|
May 12, 2021
Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8<sup>+</sup> T cell antiviral responses
Hongbing Yang, Anuska Llano, Samandhy Cedeño, et al.
AIDS (London, England)
|
October 17, 2018
Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
Morgane Gossez, Genevieve Elizabeth Martin, Matthew Pace, et al.
AIDS Research and Human Retroviruses
|
December 6, 2016
Short Communication: Lack of Effect of Maraviroc Intensification on Blood and Gut Reservoir
Juan Tiraboschi, Shuvra Ray, Kemal Patel, et al.
The Journal of Infectious Diseases
|
November 29, 2019
Levels of Human Immunodeficiency Virus DNA Are Determined Before ART Initiation and Linked to CD8 T-Cell Activation and Memory Expansion
Genevieve E Martin, Matthew Pace, Freya M Shearer, et al.
Plos Pathogens
|
July 15, 2016
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection
Matthias Hoffmann, Nikos Pantazis, Genevieve E Martin, et al.
AIDS (London, England)
|
June 15, 2021
Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohort
Luke A Granger, Isabella Huettner, Franka Debeljak, et al.
Mucosal Immunology
|
June 27, 2019
CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype
John P Thornhill, Matthew Pace, Genevieve E Martin, et al.
Frontiers in Immunology
|
May 22, 2018
CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA
Genevieve E Martin, Matthew Pace, John P Thornhill, et al.
Elife
|
September 14, 2014
HIV-1 DNA predicts disease progression and post-treatment virological control
James P Williams, Jacob Hurst, Wolfgang Stöhr, et al.
The New England Journal of Medicine
|
January 18, 2013
Short-course antiretroviral therapy in primary HIV infection
, Sarah Fidler, Kholoud Porter, et al.
Page
of 12